Syndax Pharmaceuticals (SNDX) Change in Cash (2015 - 2026)

Syndax Pharmaceuticals' Change in Cash history runs 12 years deep, the most recent figure standing at -$4.0 million for Q1 2026.

• In Q1 2026, Change in Cash fell 4385.56% year-over-year to -$4.0 million; the TTM figure through Mar 2026 stood at -$23.2 million (down 158.95% YoY), while the FY2025 annual figure was -$19.3 million, up 86.36% from the prior year.
• Change in Cash for Q1 2026 stood at -$4.0 million, down from $18.0 million in the prior quarter.
• The five-year high for Change in Cash was $200.8 million in Q4 2023, with the low at -$180.8 million in Q1 2024.
• The 5-year median for Change in Cash is -$2.7 million (2023), against an average of -$5.4 million.
• The sharpest annual moves came in 2023 and 2026: Change in Cash jumped 6641.99% in 2023, then tumbled 4385.56% in 2026.
• Syndax Pharmaceuticals' Change in Cash stood at $3.0 million in 2022, then surged by 6641.99% to $200.8 million in 2023, then tumbled by 89.51% to $21.1 million in 2024, then declined by 14.51% to $18.0 million in 2025, then tumbled by 122.42% to -$4.0 million in 2026.
• Business Quant data shows SNDX's Change in Cash at -$4.0 million in Q1 2026, $18.0 million in Q4 2025, and $8.2 million in Q3 2025.